KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Co-Diagnostics (CODX) over the last 4 years, with Q3 2025 value amounting to $15.6 million.

  • Co-Diagnostics' Treasury Shares changed 0.0% to $15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $15.6 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q1 2025, Co-Diagnostics' Treasury Shares is $4.8 million, which was down 0.0% from $4.8 million recorded in Q4 2024.
  • Co-Diagnostics' Treasury Shares' 5-year high stood at $4.8 million during Q4 2023, with a 5-year trough of $532440.0 in Q2 2022.
  • In the last 5 years, Co-Diagnostics' Treasury Shares had a median value of $4.2 million in 2023 and averaged $3.2 million.
  • In the last 5 years, Co-Diagnostics' Treasury Shares skyrocketed by 48664.84% in 2023 and then changed by 0.0% in 2024.
  • Over the past 4 years, Co-Diagnostics' Treasury Shares (Quarter) stood at $14.2 million in 2022, then grew by 9.6% to $15.6 million in 2023, then changed by 0.0% to $15.6 million in 2024, then changed by 0.0% to $15.6 million in 2025.
  • Its last three reported values are $15.6 million in Q3 2025, $15.6 million for Q2 2025, and $15.6 million during Q1 2025.